Skip to main content
Dawn Hershman, MD, Hematology, New York, NY

DawnLaurynHershmanMD

Hematology New York, NY

Hematologic Oncology

Professor of Medicine, Columbia/NYP

Overview of Dr. Hershman

Dr. Dawn Hershman is a hematologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Albert Einstein College of Medicine of Yeshiva University and has been in practice 23 years. Dr. Hershman accepts several types of health insurance, listed below. She is one of 64 doctors at New York-Presbyterian Hospital and one of 25 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Hematology. She has more than 100 publications and over 500 citings.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1998 - 2001
  • Columbia University School of Public Health
    Columbia University School of Public HealthMSc, Biostatistics, 2001
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1994 - 1998
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 1994
  • University of California, Los Angeles
    University of California, Los AngelesB.A., Psychology, 1987

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - Present
  • NJ State Medical License
    NJ State Medical License 2022 - 2025
  • NY State Medical License
    NY State Medical License 1995 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Top Doctors: New York Metro Area Castle Connolly, 2011-2014
  • Breast Cancer Medical Advancement Award AVON, 2010
  • Leadership Development Program Awardee ASCO, 2009
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women with Early-Stage Breast CancerA Randomized Clin...  
    Dawn L Hershman, Jillian L Capodice, William H Kreisle, Michael J Fisch, Marianne K Melnik, Alice T Kengla, Carla W Jorgensen, Heather Greenlee, JAMA
  • Recommendations for Obesity Clinical Trials in Cancer Survivors: American Society of Clinical Oncology Statement  
    Ligibel JA, Alfano CM, Hershman DL, Ballard RM, Bruinooge SS, Courneya KS, Daniels EC, Demark-Wahnefried W, Frank ES, Goodwin PJ, Irwin ML, Levit LA, McCaskill-Stevens..., J Clin Oncol, 1/31/2015
  • Population-based assessment of determining predictors for quality of prostate cancer surveillance  
    Chamie K, Williams SB, Hershman DL, Wright JD, Nguyen PL, Hu JC, Cancer, 1/26/2015
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • Association of baseline cardiovascular risk factors and health care utilization and costs in elderly breast cancer patients enrolled in SWOG clinical trials. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Randomized trial of text messaging (TM) to reduce early discontinuation of aromatase inhibitor (AI) therapy in women with breast cancer: SWOG S1105. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Long Term Consequences of Intermittent and Continuous Androgen Deprivation in Patients with Metastatic Prostate Cancer 
    1/1/2015
  • Join now to see all

Authored Content

  • Characteristics Associated with Prolonged Length of Stay After Hysterectomy for Benign Gynecologic ConditionsMay 2018

Press Mentions

  • Study Highlights Long-Term Risks of Prostate Cancer Treatment
    Study Highlights Long-Term Risks of Prostate Cancer TreatmentNovember 6th, 2024
  • Risk Model Identifies Advanced Cancer Trial Patients at Highest Risk for Acute Care Use
    Risk Model Identifies Advanced Cancer Trial Patients at Highest Risk for Acute Care UseSeptember 24th, 2024
  • New Model Identifies Cancer Patients at High Risk for ER Visits During Clinical Trials
    New Model Identifies Cancer Patients at High Risk for ER Visits During Clinical TrialsSeptember 22nd, 2024
  • Join now to see all

Grant Support

  • Acupuncture For Aromatase Inhibitor-Related Arthralgias In Breast Cancer PatientsNational Center For Complementary &Alternative Medicine2011–2012
  • Determinants And Risks Of Use And Overuse Of Expensive Oncology DrugsNational Cancer Institute2008–2011
  • Osteoporosis Prevention In Early Stage Breast CancerNational Cancer Institute2002–2006
  • Pilot--Ethnic Neutropenia In African-Americans And Afro-CaribbeansNational Cancer Institute2003
  • Pilot--Ethnic Neutropenia In African Americans And Afro-National Cancer Institute2003

Professional Memberships

Insurance Accepted

  • Anthem Blue Access PPO
    Anthem Blue Preferred HMO
    BCBS Blue Card PPO
    BCBS Illinois PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    GHI PPO
    Great West PPO
    HIP of New York - Select PPO
    Humana ChoiceCare Network PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment